Overview

A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence

Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This study will measure the amount of buprenorphine found in the blood after taking sublingual buprenorphine tablets versus after implantation with 4 Probuphine (buprenorphine implants).
Phase:
Phase 3
Details
Lead Sponsor:
Titan Pharmaceuticals
Treatments:
Analgesics, Opioid
Buprenorphine